Selvita
Update in progressSLV.WA (Warsaw)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
Selvita S.A. is a global contract research organization delivering end-to-end drug discovery and development services. We provide AI-driven and antibody drug discovery, structural biology, protein production, assay development and screening, CAD, medicinal chemistry, scale-up, ADME/DMPK, in vitro and in vivo pharmacology, translational research, toxicology, formulation, CMC support, GMP manufacturing and bioanalysis. Therapeutic focus includes oncology, infectious diseases, immunology, neurology and more. We also offer agrochemistry and flavor/fragrance R&D. Founded in 2007 in Kraków, Poland.
Company score
- Sentiment
- 0.27
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.17
- Governance
- 0.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.08
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.17
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!